おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Bivision
company
About
Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).
- 11 - 50
Details
- Last Funding Type
- Angel
- Last Funding Money Raised
- ¥100M
- Industries
- Biopharma,Health Diagnostics
- Founded date
- Jan 1, 2021
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
Bivision has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Aug 10, 2022 from a Angel round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 10, 2022 | Angel | ¥100M | 3 |
Gaorong Capital
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Bivision is funded by 3 investors.
Gaorong Capital
and Lichen Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Gaorong Capital
|
Yes | Angel |
|
|
— | Angel |
VI Ventures
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
